Health & Life Sciences

Overview

As a stakeholder in the health and life sciences sector, you work every day to improve human health and enhance patient care. Our national health and life sciences team partners with industry leaders like you — biotech innovators, pharmaceutical and medical device manufacturers, health systems, investors, and digital health pioneers — to help you thrive in a landscape defined by rapid change and increasingly complex regulatory demands.

Our professionals have extensive practical experience to help you navigate the sector’s most critical business and legal challenges. We advise on transformative mergers and acquisitions, strategic investments, and capital deployment, ensuring your transactions are efficient and positioned for long-term growth and innovation. Our team handles high-stakes litigation and government investigations, providing sophisticated advocacy and clear strategic guidance when challenges arise.

We support you throughout the business life cycle — structuring and negotiating technology transactions, licensing, and collaborations; guiding you through complex regulatory requirements at all stages of the product lifecycle; and implementing proactive risk management and compliance solutions. Our capabilities also encompass employee benefits and executive compensation, privacy and data security, outsourcing, intellectual property, and public policy strategy, helping you seize opportunities and mitigate risk in every aspect of your operations.

Our team includes former in-house counsel to major health systems and global life sciences companies, as well as former FDA, other federal agency and Capitol Hill health policy advisors, and former Department of Justice attorneys. With this blend of industry insight and legal acumen, we deliver practical, business-minded solutions tailored to your most complex challenges so you can continue advancing your mission and achieving your strategic objectives in a rapidly evolving sector.

Health & Life Sciences

Overview

Health & Life Sciences Sectors

Insights & Events

Latest

Jennifer Breuer Discusses Latest Telehealth Developments on AHLA’s Speaking of Health Law Podcast

Federal Court Upholds Washington State’s Commercial Electronic Mail Act against CAN-SPAM Preemption Argument

Department of Homeland Security’s Weighted Selection Process for H-1B Cap-Subject Petitions

State & Local Employment Law Developments: Q1 2026 (and Beyond)

Faegre Drinker Announces 2026 Leadership Transitions

Five Things to Know Now About New York’s Mandatory Greenhouse Gas Emissions Reporting Program

It’s Time to Adopt the Standard Accrual Rule for Civil RICO Claims

Faegre Drinker Recognized Among Top Antitrust Firms in GCR 100 for 2026

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

Insights

Jennifer Breuer Discusses Latest Telehealth Developments on AHLA’s Speaking of Health Law Podcast

Federal Court Upholds Washington State’s Commercial Electronic Mail Act against CAN-SPAM Preemption Argument

Department of Homeland Security’s Weighted Selection Process for H-1B Cap-Subject Petitions

State & Local Employment Law Developments: Q1 2026 (and Beyond)

Five Things to Know Now About New York’s Mandatory Greenhouse Gas Emissions Reporting Program

It’s Time to Adopt the Standard Accrual Rule for Civil RICO Claims

Megan Herber and Nisha Quasba Discuss Reintroduction of NSGC’s Genetic Counseling Bill

Key Updates in FDA’s 2026 General Wellness and Clinical Decision Support Software Guidance

Three District Courts Quash DOJ Subpoenas Investigating Gender-Affirming Care

Top 10 Noncompete Developments of 2025

Events

Past Events

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

Privacy and Genetic Data

Acquisitions and Divestitures: Perspectives on Buying and Selling Assets

2025 IAIR Technical Development Series Workshop

News

Faegre Drinker Announces 2026 Leadership Transitions

Faegre Drinker Recognized Among Top Antitrust Firms in GCR 100 for 2026

Faegre Drinker Wins Trial for Surmodics in High-Profile Merger Challenge Against FTC

Faegre Drinker Launches Cross-Service National Security Team

Molly Madden Receives 2025 Young Alumni Award From DePauw University

Faegre Drinker Attorneys & Product Liability & Mass Torts Group Recognized in LMG Life Sciences Rankings

Public Company and Corporate Governance Advisor Angie Snavely Rejoins Faegre Drinker as Partner in Minneapolis

Claire Nilson, Abilio Jaribu Shortlisted for 2025 Expatriate Management and Mobility Awards

Faegre Drinker Welcomes Jared Hershberg to Corporate Practice in New York

Jonathan Keller and Helen Tuttle Recognized in 2025 New Jersey Legal Awards

Related Legal Services

Experience

Our Experience

Surmodics Inc. Agrees to $627M Acquisition by GTCR

Mineralys Therapeutics, Inc. Enters into $100M ATM Equity Offering Sales Agreement

Cook Medical Litigates National MDL Involving IVC Filter

Elevance Health Enters Strategic Partnership to Advance Primary Care Delivery

Faegre Drinker Represents Miromatrix Medical Inc. in Sale of Company to United Therapeutics Corporation

TT Capital Partners Purchases All Equity Interests of Cantata Health Solutions

Meet The Team

Meet The Team

Maureen Donahue Hardwick

David F. Abernethy

Jessica C. Abrahams

Reed Abrahamson

Alison M. Agnew

Stephanie Albrecht

Nicholas B. Alford

Andrew Anderson

Josh Anderson

Lynne Anne Anderson

Emilija Andrulyte

Nicholas R. Arens

Chemaine A. Athias-Williams

Maddie Augustus

Abdullah M. Azkalany

Brian M. Balduzzi

Peter W. Baldwin

Ian J. Bambrick

Libby Baney Burstein

Michael N. Baxter

Tricia A. Beckmann

Clark A. Belanger

Trevor J. Belden

Stephen Bennett

Lacey M. Berkshire